Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma

被引：0
|
作者：
Guo, S-S. [1 ]
Chen, Q. Y. [1 ]
Liu, L. [1 ]
Sun, R. [1 ]
Wang, P. [1 ]
Li, D. [2 ]
机构：
[1] Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Nasopharyngeal Carcinoma, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.467
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
359MO
引用
收藏
页码：S1609 / S1609
页数：1
相关论文
共 50 条
  • [1] Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma
    Chen, Yu
    Luo, Mei-Juan
    Liu, Rong-Ping
    Jin, Jing
    Deng, Sheng-Wen
    Tang, Lin-Quan
    Li, Xiao-Yun
    Liu, Li-Ting
    Luo, Dong-Hua
    Sun, Rui
    Liu, Sai-Lan
    Li, Ji-Bin
    Liu, Qing
    Wang, Pan
    Chen, Qiu-Yan
    Mai, Hai-Qiang
    Guo, Shan-Shan
    RADIOTHERAPY AND ONCOLOGY, 2024, 191
  • [2] A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma
    Ke, Liang-Ru
    Xia, Wei-Xiong
    Qiu, Wen-Ze
    Huang, Xin-Jun
    Yu, Ya-Hui
    Liang, Hu
    Liu, Guo-Ying
    Xiang, Yan-Qun
    Guo, Xiang
    Lv, Xing
    ORAL ONCOLOGY, 2017, 70 : 7 - 13
  • [3] Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynx
    Loong, H. H.
    Winquist, E.
    Waldron, J.
    Chen, E. X.
    Kim, J.
    Palma, D.
    Read, N.
    Razak, A. R. A.
    Diaz-Padilla, I.
    Chan, K.
    Bayley, A.
    Hossain, M.
    Wang, L.
    Chin, S.
    Siu, L. L.
    Hope, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (13) : 2263 - 2270
  • [4] Phase Ⅱ study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and cisplatin in locally advanced nasopharyngeal carcinoma
    Yuan Wu
    Xueyan Wei
    Zilong Yuan
    Hongbin Xu
    Yanping Li
    Ying Li
    Liu Hu
    Guang Han
    Yu Qian
    Desheng Hu
    ChineseJournalofCancerResearch, 2020, 32 (05) : 665 - 672
  • [5] Durable response of tislelizumab plus cisplatin, nab-paclitaxel followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A case report
    Tang, Haifeng
    Yang, Donghong
    Luo, Guoqing
    He, Jiaqi
    Yi, Guihua
    Chen, Zihong
    Li, Haiwen
    Luo, Qianbing
    Huang, Ningxin
    Luo, Haiqing
    MEDICINE, 2023, 102 (07) : E32924
  • [6] Phase II study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and cisplatin in locally advanced nasopharyngeal carcinoma
    Wu, Yuan
    Wei, Xueyan
    Yuan, Zilong
    Xu, Hongbin
    Li, Yanping
    Li, Ying
    Hu, Liu
    Han, Guang
    Qian, Yu
    Hu, Desheng
    CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (05) : 665 - 672
  • [7] Nab-paclitaxel plus cisplatin versus docetaxel plus cisplatin and 5-FU induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A multicenter parallel controlled phase III trial.
    Lv, Xing
    Zeng, Qi
    Zhang, Weijun
    Cheng, Hao
    Xia, Weixiong
    Yanqun, Xiang
    Liang, Hu
    Cao, Xun
    Chen, Xi
    Zhan, Zejiang
    Deng, Ying
    Zhou, Jiayu
    Zhang, Lulu
    Liang, Chixiong
    Huang, Haoyang
    Huang, Yingying
    Cai, Zhuocheng
    Guo, Xiang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Induction chemotherapy with nab-paclitaxel plus nedaplatin plus concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A retrospective real-world study
    Yan Fengqin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Comparison of Concurrent Chemoradiotherapy versus Induction Chemotherapy Followed by Radiation in Patients with Nasopharyngeal Carcinoma
    Komatsu, Masanori
    Tsukuda, Mamoru
    Matsuda, Hideki
    Horiuchi, Choichi
    Taguch, Takahide
    Takahashi, Masahiro
    Nishimura, Gohshi
    Mori, Makiko
    Niho, Tatuo
    Ishitoya, Junichi
    Sakuma, Yasunori
    Hirama, Mariko
    Shiono, Osamu
    ANTICANCER RESEARCH, 2012, 32 (02) : 681 - 686
  • [10] Chemoradiotherapy Combined with Nab-Paclitaxel plus Cisplatin in Patients with Locally Advanced Borderline Resectable or Unresectable Esophageal Squamous Cell Carcinoma: A Phase I/II Study
    Yu, N.
    Li, J.
    Chen, X.
    Wang, Z.
    Kang, X.
    Zhang, R.
    Qin, J.
    Zheng, Q.
    Feng, G.
    Deng, L.
    Zhang, T.
    Wang, W.
    Liu, W., Jr.
    Wang, J.
    Feng, Q.
    Lv, J.
    Chen, D.
    Zhou, Z.
    Xiao, Z.
    Li, Y.
    Bi, N.
    Li, Y.
    Wang, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E354 - E354
12345